CytoDyn Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

461.33M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2025	-	-	-
May 31, 2024	-	-	-
May 31, 2023	-	-	-
May 31, 2022	266.00K	-	-
May 31, 2021	-	-	-
May 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
May 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
May 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
May 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
May 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Vaxart	255.61M
BioStem Technologies	37.65M
Sangamo Therapeutics	34.56M
Nuo Therapeutics	4.13M
Northwest Biotherapeutics	1.50M
Silence Therapeutics	839.00K

Revenue Rankings

CytoDyn News

8 days ago - CytoDyn Transcript: 16th Annual LD Micro Invitational Conference - Transcripts
12 days ago - CytoDyn to Present at the LD Micro Invitational XVI - GlobeNewsWire
26 days ago - CytoDyn Transcript: Study update - Transcripts
4 weeks ago - CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer - GlobeNewsWire
4 weeks ago - CytoDyn to Host Investor Webcast - GlobeNewsWire
5 weeks ago - CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 - GlobeNewsWire
5 weeks ago - CytoDyn Registration statement: Registration filing - Filings
5 weeks ago - CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study - GlobeNewsWire

More News